Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy
Key points 1. SyMRI showed excellent performance in predicting disease progression in NPC. 2. T1_Kurtosis and ADC were independent predictors of progression-free survival. 3. T1_Kurtosis was lower in the non-disease progression group than the disease progression group. 4. Combination of SyMRI, DWI,...
| Published in: | Insights into Imaging |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
SpringerOpen
2023-04-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13244-023-01411-y |
| _version_ | 1850133924301242368 |
|---|---|
| author | Fan Yang Haoran Wei Xiaolu Li Xiaoduo Yu Yanfeng Zhao Lin Li Yujie Li Lizhi Xie Sicong Wang Meng Lin |
| author_facet | Fan Yang Haoran Wei Xiaolu Li Xiaoduo Yu Yanfeng Zhao Lin Li Yujie Li Lizhi Xie Sicong Wang Meng Lin |
| author_sort | Fan Yang |
| collection | DOAJ |
| container_title | Insights into Imaging |
| description | Key points 1. SyMRI showed excellent performance in predicting disease progression in NPC. 2. T1_Kurtosis and ADC were independent predictors of progression-free survival. 3. T1_Kurtosis was lower in the non-disease progression group than the disease progression group. 4. Combination of SyMRI, DWI, and clinical factors could improve the predictive performance. |
| format | Article |
| id | doaj-art-9bfa9f2b16ff4f83acfd08076d72f267 |
| institution | Directory of Open Access Journals |
| issn | 1869-4101 |
| language | English |
| publishDate | 2023-04-01 |
| publisher | SpringerOpen |
| record_format | Article |
| spelling | doaj-art-9bfa9f2b16ff4f83acfd08076d72f2672025-08-19T23:51:48ZengSpringerOpenInsights into Imaging1869-41012023-04-0114111210.1186/s13244-023-01411-yPretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapyFan Yang0Haoran Wei1Xiaolu Li2Xiaoduo Yu3Yanfeng Zhao4Lin Li5Yujie Li6Lizhi Xie7Sicong Wang8Meng Lin9Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeDepartment of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeMR Research China, GE HealthcareMR Research China, GE HealthcareDepartment of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeKey points 1. SyMRI showed excellent performance in predicting disease progression in NPC. 2. T1_Kurtosis and ADC were independent predictors of progression-free survival. 3. T1_Kurtosis was lower in the non-disease progression group than the disease progression group. 4. Combination of SyMRI, DWI, and clinical factors could improve the predictive performance.https://doi.org/10.1186/s13244-023-01411-ySynthetic magnetic resonance imaging (SyMRI)Nasopharyngeal carcinoma (NPC)Treatment outcome |
| spellingShingle | Fan Yang Haoran Wei Xiaolu Li Xiaoduo Yu Yanfeng Zhao Lin Li Yujie Li Lizhi Xie Sicong Wang Meng Lin Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy Synthetic magnetic resonance imaging (SyMRI) Nasopharyngeal carcinoma (NPC) Treatment outcome |
| title | Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy |
| title_full | Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy |
| title_fullStr | Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy |
| title_full_unstemmed | Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy |
| title_short | Pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy |
| title_sort | pretreatment synthetic magnetic resonance imaging predicts disease progression in nonmetastatic nasopharyngeal carcinoma after intensity modulation radiation therapy |
| topic | Synthetic magnetic resonance imaging (SyMRI) Nasopharyngeal carcinoma (NPC) Treatment outcome |
| url | https://doi.org/10.1186/s13244-023-01411-y |
| work_keys_str_mv | AT fanyang pretreatmentsyntheticmagneticresonanceimagingpredictsdiseaseprogressioninnonmetastaticnasopharyngealcarcinomaafterintensitymodulationradiationtherapy AT haoranwei pretreatmentsyntheticmagneticresonanceimagingpredictsdiseaseprogressioninnonmetastaticnasopharyngealcarcinomaafterintensitymodulationradiationtherapy AT xiaoluli pretreatmentsyntheticmagneticresonanceimagingpredictsdiseaseprogressioninnonmetastaticnasopharyngealcarcinomaafterintensitymodulationradiationtherapy AT xiaoduoyu pretreatmentsyntheticmagneticresonanceimagingpredictsdiseaseprogressioninnonmetastaticnasopharyngealcarcinomaafterintensitymodulationradiationtherapy AT yanfengzhao pretreatmentsyntheticmagneticresonanceimagingpredictsdiseaseprogressioninnonmetastaticnasopharyngealcarcinomaafterintensitymodulationradiationtherapy AT linli pretreatmentsyntheticmagneticresonanceimagingpredictsdiseaseprogressioninnonmetastaticnasopharyngealcarcinomaafterintensitymodulationradiationtherapy AT yujieli pretreatmentsyntheticmagneticresonanceimagingpredictsdiseaseprogressioninnonmetastaticnasopharyngealcarcinomaafterintensitymodulationradiationtherapy AT lizhixie pretreatmentsyntheticmagneticresonanceimagingpredictsdiseaseprogressioninnonmetastaticnasopharyngealcarcinomaafterintensitymodulationradiationtherapy AT sicongwang pretreatmentsyntheticmagneticresonanceimagingpredictsdiseaseprogressioninnonmetastaticnasopharyngealcarcinomaafterintensitymodulationradiationtherapy AT menglin pretreatmentsyntheticmagneticresonanceimagingpredictsdiseaseprogressioninnonmetastaticnasopharyngealcarcinomaafterintensitymodulationradiationtherapy |